1,107 reports of this reaction
4.8% of all CRIZOTINIB reports
#4 most reported adverse reaction
NAUSEA is the #4 most commonly reported adverse reaction for CRIZOTINIB, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 1,107 FDA adverse event reports linking CRIZOTINIB to NAUSEA. This represents approximately 4.8% of all 22,895 adverse event reports for this drug.
Patients taking CRIZOTINIB who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is moderately reported among CRIZOTINIB users, representing a notable but not dominant share of adverse events.
In addition to nausea, the following adverse reactions have been reported for CRIZOTINIB:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 1,107 FDA reports for CRIZOTINIB. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 4.8% of all adverse event reports for CRIZOTINIB, making it a notable side effect.
If you experience nausea while taking CRIZOTINIB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.